NARF Is a Hypoxia-Induced Coactivator for OCT4-Mediated Breast Cancer Stem Cell Specification

Researchers identified nuclear prelamin A recognition factor (NARF) as a hypoxia-inducible, hypoxia-inducible factor 1 target gene in human breast cancer cells.